Noteworthy

Sep 20, 2018
Pharmaceutical Executive
While definitions for “specialty drug” vary, this once-niche treatment market may be poised to steer the future of prescription medicine and patient care.
Sep 19, 2018
Pharmaceutical Executive
Executives highlight approaches around recent landmark approvals for digital medicine and gene therapy.
Sep 14, 2018
Pharmaceutical Executive
How one nonprofit and its out-front leader are joining forces with industry to advance a new personalized medicine approach for cystic fibrosis patients with nonsense mutations.
Sep 13, 2018
Pharmaceutical Executive
How low-cost drugs can succeed in the specialty pharmacy channel, by Charlie Bell.
Sep 12, 2018
The marketing challenge for pharmaceutical companies has now shifted to "How can we successfully and cost-effectively assist providers in orchestrating better care?" William Febbo reports.
Sep 11, 2018
Pharmaceutical Executive
A list of five essential features a building must have in order to be considered lab-ready.
Sep 10, 2018
Pharmaceutical Executive
An overview of Orphan Reinsurer and Benefit Managers groups, including potential challenges with the model and various model suggestions.
Sep 10, 2018
Paras Kumar examines the critical role that patent research has within life sciences beyond its traditional uses by the R&D and legal departments.
Sep 10, 2018
To succeed in developing targeted medicines, companies need a biomarker strategy and the expertise to make smart decisions about clinical trial design, assays, technology platforms and collaborative partners.
Aug 31, 2018
Designing and managing clinical outcome assessments on an international basis is more than a translation task. It requires the more discrete practice of linguistic validation, writes Dana Weiss.
native1_300x100
lorem ipsum